home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 02/14/19

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - MFGP, AZN among premarket gainers

Reebonz Holding ( RBZ ) +76% . More news on: Reebonz Holding Ltd. Class A, Invacare Corporation, Electrameccanica Vehicles Corp. Ltd., Stocks on the move, Read more ...

DBVT - Tech dominate after hours movers

Gainers: IVC   +19.3% . DBVT   +19.1% . SNBR   +11.1% . YELP   +6.3% . VNDA   +5.0% . More news on: Presidio, Invacare Corporation, DBV Technologies, , Stocks on the move, News on ETFs, Read more ...

DBVT - DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age

Montrouge, France, February 13, 2019 DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age Progress made to date to enable BLA resubmission in Q3 2019 Company to hold conference call today, Febr...

DBVT - DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company

                                                                                  &#x...

DBVT - Aimmune Suffers Delay, But Not Of Its Own Making

Aimmune ( AIMT ) suffered a setback and through no fault of its own. It was notified by the FDA that its Biologics Licensing Application ((BLA)) would not be reviewed because of the government shutdown. The stock fell about 5% on Monday after the release of the news, and then slightly ag...

DBVT - DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019

DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019 Novel immunotherapy based on Viaskin technology highlighted as a potential treatment for food-allergic patients DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinic...

DBVT - DBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference

DBV Technologies to Present at the 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Off...

Previous 10 Next 10